Literature DB >> 11108659

Inactivation of MMAC1 in bladder transitional-cell carcinoma cell lines and specimens.

J Liu1, D C Babaian, M Liebert, P A Steck, J Kagan.   

Abstract

We recently limited the location of a candidate tumor suppressor gene in invasive (T3a/b) bladder transitional-cell carcinoma (TCC) to a 2.5-cM region at chromosome 10q23.3. This region harbors the MMAC1/PTEN/TEP1 gene (referred to hereafter as MMAC1), a dual-phosphatase tumor-suppressor gene frequently inactivated in variety of malignant tumors. In the present study, we examined whether MMAC1 is a target for inactivation by mutations and deletions in bladder TCC cell lines and specimens. MMAC1 was inactivated by homozygous deletions and mutations in three (27%) of 11 bladder cancer cell lines. One cell line, UC-3, had homozygous deletions, and two other cell lines, T-24 and UC-9, had missense mutations. T-24 had also a nonsense mutation. However, none of the 33 bladder TCC specimens examined had a mutation or deletion in the coding region. These results suggest that MMAC1 is not the primary target for inactivation in bladder TCC and that another gene, in close proximity to the MMAC1 locus, within this region of frequent allelic losses, may be the target for inactivation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108659     DOI: 10.1002/1098-2744(200011)29:3<143::aid-mc3>3.0.co;2-a

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  7 in total

1.  A role for Akt in the rapid regulation of inflammatory and apoptotic pathways in mouse bladder.

Authors:  Frank J Tamarkin; Walter S Kang; Justin J Cohen; Marcia A Wheeler; Robert M Weiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-07-11       Impact factor: 3.000

2.  Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma.

Authors:  Donna E Hansel; Eric Platt; Mohammed Orloff; Jyoti Harwalker; Swathi Sethu; Jessica L Hicks; Angelo De Marzo; Roxanne E Steinle; Eric D Hsi; Dan Theodorescu; Christina B Ching; Charis Eng
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

Review 3.  Molecular pathogenesis of bladder cancer.

Authors:  Margaret A Knowles
Journal:  Int J Clin Oncol       Date:  2008-08-15       Impact factor: 3.402

4.  Evaluation of PTEN and CD4+FOXP3+ T cell expressions as diagnostic and predictive factors in endometrial cancer: A case control study.

Authors:  Zeng Xi; Li Jing; Kang Le-Ni; Lan Zhu; Deng Ze-Wen; Ye Hui; Xi Ming-Rong; Liao Guang-Dong
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

Review 5.  Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer.

Authors:  Margaret A Knowles; Fiona M Platt; Rebecca L Ross; Carolyn D Hurst
Journal:  Cancer Metastasis Rev       Date:  2009-12       Impact factor: 9.264

Review 6.  Biology of urothelial tumorigenesis: insights from genetically engineered mice.

Authors:  Xue-Ru Wu
Journal:  Cancer Metastasis Rev       Date:  2009-12       Impact factor: 9.264

7.  Different molecular patterns in glioblastoma multiforme subtypes upon recurrence.

Authors:  Ramon Martinez; Veit Rohde; Gabriele Schackert
Journal:  J Neurooncol       Date:  2009-07-31       Impact factor: 4.130

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.